このリソースは患者のアレルギー不耐症を表現する。具体的には、特定の物質または物質群への暴露によって生じる有害反応の傾向や、潜在的なリスクを表現する。

このアレルギー不耐症のステータス。

特定された物質（医薬品を含む）が有害反応を誘発する確実性の度合い。

有害反応を誘発する生理的なメカニズムが特定できる場合にアレルギーか不耐性かを区別する。

同定された物質のカテゴリー。

同定された物質が誘発する有害反応の臨床的な重要度。

Code for an allergy or intolerance statement (either a positive or a negated/excluded statement). This may be a code for a substance or pharmaceutical product that is considered to be responsible for the adverse reaction risk (e.g., "Latex"), an allergy or intolerance condition (e.g., "Latex allergy"), or a negated/excluded code for a specific substance or class (e.g., "No latex allergy") or a general or categorical negated statement (e.g., "No known allergy", "No known drug allergies"). Note: the substance for a specific reaction may be different from the substance identified as the cause of the risk, but it must be consistent with it. For instance, it may be a more specific substance (e.g. a brand medication) or a composite product that includes the identified substance. It must be clinically safe to only process the 'code' and ignore the 'reaction.substance'. If a receiving system is unable to confirm that AllergyIntolerance.reaction.substance falls within the semantic scope of AllergyIntolerance.code, then the receiving system should ignore AllergyIntolerance.reaction.substance.

アレルギー不耐症を識別するためのコード（肯定または否定・除外の両者を含む）。このコードは、アレルゲンとなる物資（例:Latex）、状態としてのアレルギー不耐性（例:Latex allergy）、特定の物質やクラスに対する否定・除外コード（例: No latex allergy）、物質やクラス全般に対する否定・除外コード（例: No known allergy, No known drug allergies）などが考えられる。

注: 特定の有害反応を誘発する物質は、原因として特定された物質と異なっていてもよいが、整合がとれていなければならない。たとえば、より具体的な物質（ブランド薬など）や、特定された物質を含む複合製品の場合がある。 AllergyIntolerance.codeのみを処理し、AllergyIntolerance.reaction.substanceを無視しても、臨床的に安全でなければならない。 受信システムがAllergyIntolerance.reaction.substanceがAllergyIntolerance.codeのセマンティックスコープ内に（前者が後者の意味的な下位概念にあること）を確認できない場合、受信システムはAllergyIntolerance.reaction.substanceを無視する必要がある。

このプロファイルを利用するにあたっては注意事項も参照のこと。https://jami-fhir-jp-wg.github.io/jp-core-v1xpages/jpcore-r4/develop/StructureDefinition-jp-allergyintolerance.html#%E6%B3%A8%E6%84%8F%E4%BA%8B%E9%A0%85

このアレルギー不耐症を有する患者。

このアレルギー不耐症が判明した受療の状況（外来、入院、救急、在宅など）

Estimated or actual date, date-time, or age when allergy or intolerance was identified.

このアレルギー不耐症が同定された事実もしくは推定された時期（日付、日時、年齢）。

The recordedDate represents when this particular AllergyIntolerance record was created in the system, which is often a system-generated date. このアレルギー不耐症の記録がシステムで作成された日時を表し、多くの場合、システムが生成した日付である。

このアレルギー不耐症を記録しその内容に責任を持つ個人。

このアレルギー不耐症に関する情報の発生源または取得元。

最も直近に発生した日時を表す。

他のフィールド要素では表現できない、このアレルギー不耐症に関する追加的な記述。

同定された物質への暴露に関連する個々の有害反応に関する詳細情報。

有害反応の原因と考えられる物質（または医薬品）。

注：特定の有害反応を誘発する物質は、原因として特定された物質と異なっていてもよいが、整合がとれていなければならない。たとえば、より具体的な物質（ブランド薬など）や、特定された物質を含む複合製品の場合がある。 AllergyIntolerance.codeのみを処理し、AllergyIntolerance.reaction.substanceを無視しても、臨床的に安全でなければならない。 受信システムがAllergyIntolerance.reaction.substanceがAllergyIntolerance.codeのセマンティックスコープ内に（前者が後者の意味的な下位概念にあること）を確認できない場合、受信システムはAllergyIntolerance.reaction.substanceを無視する必要がある。

この有害反応に関連する症状や兆候。

必要であれば症状兆候の詳細も含めた、有害反応全体に関するテキストによる記述。

この有害反応の開始の日付もしくは日時の記録。

有害反応の重症度の全体としての臨床的な評価で、潜在的には複数の異なる症状兆候を考慮して決める。

患者がどのような経路でこの物質に暴露したかの同定。

他のフィールド要素では記述できない、有害反応に関する追加テキスト。

このリソースは患者のアレルギー不耐症を表現する。具体的には、特定の物質または物質群への暴露によって生じる有害反応の傾向や、潜在的なリスクを表現する。

このアレルギー不耐症のステータス。

特定された物質（医薬品を含む）が有害反応を誘発する確実性の度合い。

有害反応を誘発する生理的なメカニズムが特定できる場合にアレルギーか不耐性かを区別する。

同定された物質のカテゴリー。

同定された物質が誘発する有害反応の臨床的な重要度。

Code for an allergy or intolerance statement (either a positive or a negated/excluded statement). This may be a code for a substance or pharmaceutical product that is considered to be responsible for the adverse reaction risk (e.g., "Latex"), an allergy or intolerance condition (e.g., "Latex allergy"), or a negated/excluded code for a specific substance or class (e.g., "No latex allergy") or a general or categorical negated statement (e.g., "No known allergy", "No known drug allergies"). Note: the substance for a specific reaction may be different from the substance identified as the cause of the risk, but it must be consistent with it. For instance, it may be a more specific substance (e.g. a brand medication) or a composite product that includes the identified substance. It must be clinically safe to only process the 'code' and ignore the 'reaction.substance'. If a receiving system is unable to confirm that AllergyIntolerance.reaction.substance falls within the semantic scope of AllergyIntolerance.code, then the receiving system should ignore AllergyIntolerance.reaction.substance.

アレルギー不耐症を識別するためのコード（肯定または否定・除外の両者を含む）。このコードは、アレルゲンとなる物資（例:Latex）、状態としてのアレルギー不耐性（例:Latex allergy）、特定の物質やクラスに対する否定・除外コード（例: No latex allergy）、物質やクラス全般に対する否定・除外コード（例: No known allergy, No known drug allergies）などが考えられる。

注: 特定の有害反応を誘発する物質は、原因として特定された物質と異なっていてもよいが、整合がとれていなければならない。たとえば、より具体的な物質（ブランド薬など）や、特定された物質を含む複合製品の場合がある。 AllergyIntolerance.codeのみを処理し、AllergyIntolerance.reaction.substanceを無視しても、臨床的に安全でなければならない。 受信システムがAllergyIntolerance.reaction.substanceがAllergyIntolerance.codeのセマンティックスコープ内に（前者が後者の意味的な下位概念にあること）を確認できない場合、受信システムはAllergyIntolerance.reaction.substanceを無視する必要がある。

このプロファイルを利用するにあたっては注意事項も参照のこと。https://jami-fhir-jp-wg.github.io/jp-core-v1xpages/jpcore-r4/develop/StructureDefinition-jp-allergyintolerance.html#%E6%B3%A8%E6%84%8F%E4%BA%8B%E9%A0%85

このアレルギー不耐症を有する患者。

このアレルギー不耐症が判明した受療の状況（外来、入院、救急、在宅など）

Estimated or actual date, date-time, or age when allergy or intolerance was identified.

このアレルギー不耐症が同定された事実もしくは推定された時期（日付、日時、年齢）。

The recordedDate represents when this particular AllergyIntolerance record was created in the system, which is often a system-generated date. このアレルギー不耐症の記録がシステムで作成された日時を表し、多くの場合、システムが生成した日付である。

このアレルギー不耐症を記録しその内容に責任を持つ個人。

このアレルギー不耐症に関する情報の発生源または取得元。

最も直近に発生した日時を表す。

他のフィールド要素では表現できない、このアレルギー不耐症に関する追加的な記述。

同定された物質への暴露に関連する個々の有害反応に関する詳細情報。

有害反応の原因と考えられる物質（または医薬品）。

注：特定の有害反応を誘発する物質は、原因として特定された物質と異なっていてもよいが、整合がとれていなければならない。たとえば、より具体的な物質（ブランド薬など）や、特定された物質を含む複合製品の場合がある。 AllergyIntolerance.codeのみを処理し、AllergyIntolerance.reaction.substanceを無視しても、臨床的に安全でなければならない。 受信システムがAllergyIntolerance.reaction.substanceがAllergyIntolerance.codeのセマンティックスコープ内に（前者が後者の意味的な下位概念にあること）を確認できない場合、受信システムはAllergyIntolerance.reaction.substanceを無視する必要がある。

この有害反応に関連する症状や兆候。

必要であれば症状兆候の詳細も含めた、有害反応全体に関するテキストによる記述。

この有害反応の開始の日付もしくは日時の記録。

有害反応の重症度の全体としての臨床的な評価で、潜在的には複数の異なる症状兆候を考慮して決める。

患者がどのような経路でこの物質に暴露したかの同定。

他のフィールド要素では記述できない、有害反応に関する追加テキスト。

Risk of harmful or undesirable, physiological response which is unique to an individual and associated with exposure to a substance.

このリソースは患者のアレルギー不耐症を表現する。具体的には、特定の物質または物質群への暴露によって生じる有害反応の傾向や、潜在的なリスクを表現する。

Substances include, but are not limited to: a therapeutic substance administered correctly at an appropriate dosage for the individual; food; material derived from plants or animals; or venom from insect stings.

The logical id of the resource, as used in the URL for the resource. Once assigned, this value never changes.

The only time that a resource does not have an id is when it is being submitted to the server using a create operation.

The metadata about the resource. This is content that is maintained by the infrastructure. Changes to the content might not always be associated with version changes to the resource.

A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc.

Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of it's narrative along with other profiles, value sets, etc.

The base language in which the resource is written.

Language is provided to support indexing and accessibility (typically, services such as text to speech use the language tag). The html language tag in the narrative applies to the narrative. The language tag on the resource may be used to specify the language of other presentations generated from the data in the resource. Not all the content has to be in the base language. The Resource.language should not be assumed to apply to the narrative automatically. If a language is specified, it should it also be specified on the div element in the html (see rules in HTML5 for information about the relationship between xml:lang and the html lang attribute).

A human-readable narrative that contains a summary of the resource and can be used to represent the content of the resource to a human. The narrative need not encode all the structured data, but is required to contain sufficient detail to make it "clinically safe" for a human to just read the narrative. Resource definitions may define what content should be represented in the narrative to ensure clinical safety.

Contained resources do not have narrative. Resources that are not contained SHOULD have a narrative. In some cases, a resource may only have text with little or no additional discrete data (as long as all minOccurs=1 elements are satisfied). This may be necessary for data from legacy systems where information is captured as a "text blob" or where text is additionally entered raw or narrated and encoded information is added later.

These resources do not have an independent existence apart from the resource that contains them - they cannot be identified independently, and nor can they have their own independent transaction scope.

This should never be done when the content can be identified properly, as once identification is lost, it is extremely difficult (and context dependent) to restore it again. Contained resources may have profiles and tags In their meta elements, but SHALL NOT have security labels.

May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Business identifiers assigned to this AllergyIntolerance by the performer or other systems which remain constant as the resource is updated and propagates from server to server.

Allows identification of the AllergyIntolerance as it is known by various participating systems and in a way that remains consistent across servers.

This is a business identifier, not a resource identifier (see discussion). It is best practice for the identifier to only appear on a single resource instance, however business practices may occasionally dictate that multiple resource instances with the same identifier can exist - possibly even with different resource types. For example, multiple Patient and a Person resource instance might share the same social insurance number.

The clinical status of the allergy or intolerance.

このアレルギー不耐症のステータス。

Refer to discussion if clincalStatus is missing data. The data type is CodeableConcept because clinicalStatus has some clinical judgment involved, such that there might need to be more specificity than the required FHIR value set allows. For example, a SNOMED coding might allow for additional specificity.

Assertion about certainty associated with the propensity, or potential risk, of a reaction to the identified substance (including pharmaceutical product).

特定された物質（医薬品を含む）が有害反応を誘発する確実性の度合い。

The data type is CodeableConcept because verificationStatus has some clinical judgment involved, such that there might need to be more specificity than the required FHIR value set allows. For example, a SNOMED coding might allow for additional specificity.

Identification of the underlying physiological mechanism for the reaction risk.

有害反応を誘発する生理的なメカニズムが特定できる場合にアレルギーか不耐性かを区別する。

Allergic (typically immune-mediated) reactions have been traditionally regarded as an indicator for potential escalation to significant future risk. Contemporary knowledge suggests that some reactions previously thought to be immune-mediated are, in fact, non-immune, but in some cases can still pose a life threatening risk. It is acknowledged that many clinicians might not be in a position to distinguish the mechanism of a particular reaction. Often the term "allergy" is used rather generically and may overlap with the use of "intolerance" - in practice the boundaries between these two concepts might not be well-defined or understood. This data element is included nevertheless, because many legacy systems have captured this attribute. Immunologic testing may provide supporting evidence for the basis of the reaction and the causative substance, but no tests are 100% sensitive or specific for sensitivity to a particular substance. If, as is commonly the case, it is unclear whether the reaction is due to an allergy or an intolerance, then the type element should be omitted from the resource.

Category of the identified substance.

同定された物質のカテゴリー。

This data element has been included because it is currently being captured in some clinical systems. This data can be derived from the substance where coding systems are used, and is effectively redundant in that situation. When searching on category, consider the implications of AllergyIntolerance resources without a category. For example, when searching on category = medication, medication allergies that don't have a category valued will not be returned. Refer to search for more information on how to search category with a :missing modifier to get allergies that don't have a category. Additionally, category should be used with caution because category can be subjective based on the sender.

Estimate of the potential clinical harm, or seriousness, of the reaction to the identified substance.

同定された物質が誘発する有害反応の臨床的な重要度。

The default criticality value for any propensity to an adverse reaction should be 'Low Risk', indicating at the very least a relative contraindication to deliberate or voluntary exposure to the substance. 'High Risk' is flagged if the clinician has identified a propensity for a more serious or potentially life-threatening reaction, such as anaphylaxis, and implies an absolute contraindication to deliberate or voluntary exposure to the substance. If this element is missing, the criticality is unknown (though it may be known elsewhere). Systems that capture a severity at the condition level are actually representing the concept of criticality whereas the severity documented at the reaction level is representing the true reaction severity. Existing systems that are capturing both condition criticality and reaction severity may use the term "severity" to represent both. Criticality is the worst it could be in the future (i.e. situation-agnostic) whereas severity is situation-dependent.

Code for an allergy or intolerance statement (either a positive or a negated/excluded statement). This may be a code for a substance or pharmaceutical product that is considered to be responsible for the adverse reaction risk (e.g., "Latex"), an allergy or intolerance condition (e.g., "Latex allergy"), or a negated/excluded code for a specific substance or class (e.g., "No latex allergy") or a general or categorical negated statement (e.g., "No known allergy", "No known drug allergies"). Note: the substance for a specific reaction may be different from the substance identified as the cause of the risk, but it must be consistent with it. For instance, it may be a more specific substance (e.g. a brand medication) or a composite product that includes the identified substance. It must be clinically safe to only process the 'code' and ignore the 'reaction.substance'. If a receiving system is unable to confirm that AllergyIntolerance.reaction.substance falls within the semantic scope of AllergyIntolerance.code, then the receiving system should ignore AllergyIntolerance.reaction.substance.

アレルギー不耐症を識別するためのコード（肯定または否定・除外の両者を含む）。このコードは、アレルゲンとなる物資（例:Latex）、状態としてのアレルギー不耐性（例:Latex allergy）、特定の物質やクラスに対する否定・除外コード（例: No latex allergy）、物質やクラス全般に対する否定・除外コード（例: No known allergy, No known drug allergies）などが考えられる。

注: 特定の有害反応を誘発する物質は、原因として特定された物質と異なっていてもよいが、整合がとれていなければならない。たとえば、より具体的な物質（ブランド薬など）や、特定された物質を含む複合製品の場合がある。 AllergyIntolerance.codeのみを処理し、AllergyIntolerance.reaction.substanceを無視しても、臨床的に安全でなければならない。 受信システムがAllergyIntolerance.reaction.substanceがAllergyIntolerance.codeのセマンティックスコープ内に（前者が後者の意味的な下位概念にあること）を確認できない場合、受信システムはAllergyIntolerance.reaction.substanceを無視する必要がある。

このプロファイルを利用するにあたっては注意事項も参照のこと。https://jami-fhir-jp-wg.github.io/jp-core-v1xpages/jpcore-r4/develop/StructureDefinition-jp-allergyintolerance.html#%E6%B3%A8%E6%84%8F%E4%BA%8B%E9%A0%85

The patient who has the allergy or intolerance.

このアレルギー不耐症を有する患者。

The encounter when the allergy or intolerance was asserted.

このアレルギー不耐症が判明した受療の状況（外来、入院、救急、在宅など）

Estimated or actual date, date-time, or age when allergy or intolerance was identified.

このアレルギー不耐症が同定された事実もしくは推定された時期（日付、日時、年齢）。

The recordedDate represents when this particular AllergyIntolerance record was created in the system, which is often a system-generated date. このアレルギー不耐症の記録がシステムで作成された日時を表し、多くの場合、システムが生成した日付である。

Individual who recorded the record and takes responsibility for its content.

このアレルギー不耐症を記録しその内容に責任を持つ個人。

The source of the information about the allergy that is recorded.

このアレルギー不耐症に関する情報の発生源または取得元。

The recorder takes responsibility for the content, but can reference the source from where they got it.

Represents the date and/or time of the last known occurrence of a reaction event.

最も直近に発生した日時を表す。

This date may be replicated by one of the Onset of Reaction dates. Where a textual representation of the date of last occurrence is required e.g. 'In Childhood, '10 years ago' the Comment element should be used.

Additional narrative about the propensity for the Adverse Reaction, not captured in other fields.

他のフィールド要素では表現できない、このアレルギー不耐症に関する追加的な記述。

For example: including reason for flagging a seriousness of 'High Risk'; and instructions related to future exposure or administration of the substance, such as administration within an Intensive Care Unit or under corticosteroid cover. The notes should be related to an allergy or intolerance as a condition in general and not related to any particular episode of it. For episode notes and descriptions, use AllergyIntolerance.event.description and AllergyIntolerance.event.notes.

Details about each adverse reaction event linked to exposure to the identified substance.

同定された物質への暴露に関連する個々の有害反応に関する詳細情報。

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

Identification of the specific substance (or pharmaceutical product) considered to be responsible for the Adverse Reaction event. Note: the substance for a specific reaction may be different from the substance identified as the cause of the risk, but it must be consistent with it. For instance, it may be a more specific substance (e.g. a brand medication) or a composite product that includes the identified substance. It must be clinically safe to only process the 'code' and ignore the 'reaction.substance'. If a receiving system is unable to confirm that AllergyIntolerance.reaction.substance falls within the semantic scope of AllergyIntolerance.code, then the receiving system should ignore AllergyIntolerance.reaction.substance.

有害反応の原因と考えられる物質（または医薬品）。

注：特定の有害反応を誘発する物質は、原因として特定された物質と異なっていてもよいが、整合がとれていなければならない。たとえば、より具体的な物質（ブランド薬など）や、特定された物質を含む複合製品の場合がある。 AllergyIntolerance.codeのみを処理し、AllergyIntolerance.reaction.substanceを無視しても、臨床的に安全でなければならない。 受信システムがAllergyIntolerance.reaction.substanceがAllergyIntolerance.codeのセマンティックスコープ内に（前者が後者の意味的な下位概念にあること）を確認できない場合、受信システムはAllergyIntolerance.reaction.substanceを無視する必要がある。

Coding of the specific substance (or pharmaceutical product) with a terminology capable of triggering decision support should be used wherever possible. The 'code' element allows for the use of a specific substance or pharmaceutical product, or a group or class of substances. In the case of an allergy or intolerance to a class of substances, (for example, "penicillins"), the 'reaction.substance' element could be used to code the specific substance that was identified as having caused the reaction (for example, "amoxycillin"). Duplication of the value in the 'code' and 'reaction.substance' elements is acceptable when a specific substance has been recorded in 'code'.

Clinical symptoms and/or signs that are observed or associated with the adverse reaction event.

この有害反応に関連する症状や兆候。

Manifestation can be expressed as a single word, phrase or brief description. For example: nausea, rash or no reaction. It is preferable that manifestation should be coded with a terminology, where possible. The values entered here may be used to display on an application screen as part of a list of adverse reactions, as recommended in the UK NHS CUI guidelines. Terminologies commonly used include, but are not limited to, SNOMED CT or ICD10.

Text description about the reaction as a whole, including details of the manifestation if required.

必要であれば症状兆候の詳細も含めた、有害反応全体に関するテキストによる記述。

Use the description to provide any details of a particular event of the occurred reaction such as circumstances, reaction specifics, what happened before/after. Information, related to the event, but not describing a particular care should be captured in the comment field. For example: at the age of four, the patient was given penicillin for strep throat and subsequently developed severe hives.

Record of the date and/or time of the onset of the Reaction.

この有害反応の開始の日付もしくは日時の記録。

Clinical assessment of the severity of the reaction event as a whole, potentially considering multiple different manifestations.

有害反応の重症度の全体としての臨床的な評価で、潜在的には複数の異なる症状兆候を考慮して決める。

It is acknowledged that this assessment is very subjective. There may be some specific practice domains where objective scales have been applied. Objective scales can be included in this model as extensions.

Identification of the route by which the subject was exposed to the substance.

患者がどのような経路でこの物質に暴露したかの同定。

Coding of the route of exposure with a terminology should be used wherever possible.

Additional text about the adverse reaction event not captured in other fields.

他のフィールド要素では記述できない、有害反応に関する追加テキスト。

Use this field to record information indirectly related to a particular event and not captured in the description. For example: Clinical records are no longer available, recorded based on information provided to the patient by her mother and her mother is deceased.